U.S. Department of Health Human Services. The health consequences of smoking—50 years of progress: a report of the Surgeon General. Atlanta (GA): Department of Health Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
Cornelius ME, Wang TW, Jamal A, Loretan CG, Neff LJ. Tobacco product use among adults - United States, 2019. MMWR Morb Mortal Wkly Rep. 2020;69(46):1736–42.
U.S. Department of Health and Human Services, Office of the Surgeon General, U.S. Office on Smoking and Health: How tobacco smoke causes disease : the biology and behavioral basis for smoking-attributable disease : a report of the Surgeon General. Rockville, MD: U.S. Dept. of Health and Human Services. London: Public Health Service for sale by the Supt. of Documents, U.S. G.P.O.; 2010.
McNeill A, Brose LS, Calder R, Bauld L, Robson D: Evidence review of e-cigarettes and heated tobacco products 2018. A report commissioned by public health England London. London: Public Health England; 2018, 6.
National Academies of Sciences E, and Medicine,: Public health consequences of e-cigarettes. In: Public Health Consequences of E-Cigarettes. edn. Edited by Eaton DL, Kwan LY, Stratton K. Washington (DC): The National Academies Press; 2018.
Royal College of Physicians. Nicotine without smoke: Tobacco harm reduction. London: RCP; 2016.
Abrams DB, Glasser AM, Pearson JL, Villanti AC, Collins LK, Niaura RS. Harm minimization and tobacco control: reframing societal views of nicotine use to rapidly save lives. Annu Rev Public Health. 2018;39:193–213.
FDA announces comprehensive regulatory plan to shift trajectory of tobacco-related disease, death [https://www.fda.gov/news-events/press-announcements/fda-announces-comprehensive-regulatory-plan-shift-trajectory-tobacco-related-disease-death]
Glasser AM, Collins L, Pearson JL, Abudayyeh H, Niaura RS, Abrams DB, Villanti AC. Overview of electronic nicotine delivery systems: a systematic review. Am J Prev Med. 2017;52(2):e33–66.
Nutt DJ, Phillips LD, Balfour D, Curran HV, Dockrell M, Foulds J, Fagerstrom K, Letlape K, Milton A, Polosa R. Estimating the harms of nicotine-containing products using the MCDA approach. Eur Addict Res. 2014;20(5):218–25.
Vaping and quitting smoking [https://www.canada.ca/en/health-canada/services/smoking-tobacco/vaping/smokers.html]
Vaping vs. Smoking [https://vapingfacts.health.nz/vaping-vs-smoking/]
Huang J, Feng B, Weaver SR, Pechacek TF, Slovic P, Eriksen MP. Changing perceptions of harm of e-cigarette vs cigarette use among adults in 2 US national surveys from 2012 to 2017. JAMA Netw Open. 2019;2(3):e191047.
Malt L, Verron T, Cahours X, Guo M, Weaver S, Walele T, O’Connell G. Perception of the relative harm of electronic cigarettes compared to cigarettes amongst US adults from 2013 to 2016: analysis of the Population Assessment of Tobacco and Health (PATH) study data. Harm Reduct J. 2020;17(1):65.
Abrams DB, Glasser AM, Villanti AC, Pearson JL, Rose S, Niaura RS. Managing nicotine without smoke to save lives now: Evidence for harm minimization. Prev Med. 2018;117:88–97.
Rosenstock IM. The health belief model and preventive health behavior. Health Educ Monogr. 1974;2(4):354–86.
Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179–211.
Soule EK, Plunk AD, Harrell PT, Hayes RB, Edwards KC. Longitudinal analysis of associations between reasons for electronic cigarette use and change in smoking status among adults in the population assessment of tobacco and health study. Nicotine Tob Res. 2020;22(5):663–71.
McKeganey N, Dickson T. Why don’t more smokers switch to using E-Cigarettes: the views of confirmed smokers. Int J Environ Res Public Health. 2017;14(6):647.
Majeed BA, Weaver SR, Gregory KR, Whitney CF, Slovic P, Pechacek TF, Eriksen MP. Changing perceptions of harm of E-cigarettes among U.S. adults, 2012–2015. Am J Prev Med. 2017;52(3):331–8.
Evans AT, Henderson KC, Geier A, Weaver SR, Spears CA, Ashley DL, Fritz M, John L, Pechacek TF. What Motivates Smokers to Switch to ENDS? A Qualitative Study of Perceptions and Use. Int J Environ Res Public Health. 2020;17(23):8865.
Technical Project Lead Review of PMTAs [https://www.fda.gov/media/153017/download]
Hughes JR, Peters EN, Naud S. Relapse to smoking after 1 year of abstinence: a meta-analysis. Addict Behav. 2008;33(12):1516–20.
Jackson SE, McGowan JA, Ubhi HK, Proudfoot H, Shahab L, Brown J, West R. Modelling continuous abstinence rates over time from clinical trials of pharmacological interventions for smoking cessation. Addiction. 2019;114(5):787–97.
Brose LS, Bowen J, McNeill A, Partos TR. Associations between vaping and relapse to smoking: preliminary findings from a longitudinal survey in the UK. Harm Reduct J. 2019;16(1):76.
Dai H, Leventhal AM. Association of electronic cigarette vaping and subsequent smoking relapse among former smokers. Drug Alcohol Depend. 2019;199:10–7.
Hyland A, Ambrose BK, Conway KP, Borek N, Lambert E, Carusi C, Taylor K, Crosse S, Fong GT, Cummings KM, et al. Design and methods of the Population Assessment of Tobacco and Health (PATH) Study. Tob Control. 2017;26(4):371–8.
National Cancer Institute: 2018–19 Summary Table Technical Notes. https://cancercontrol.cancer.gov/brp/tcrb/tus-cps/results/2018-2019/technical-notes. 2020.
Centers for Disease Control and Prevention: National Health Interview Survey. Glossary. https://www.cdc.gov/nchs/nhis/tobacco/tobacco_glossary.htm. 2017.
Persoskie A, O’Brien EK, Poonai K. Perceived relative harm of using e-cigarettes predicts future product switching among US adult cigarette and e-cigarette dual users. Addiction. 2019;114(12):2197–205.
Fong GT, Elton-Marshall T, Driezen P, Kaufman AR, Cummings KM, Choi K, Kwan J, Koblitz A, Hyland A, Bansal-Travers M, et al. U.S. adult perceptions of the harmfulness of tobacco products: descriptive findings from the 2013–14 baseline wave 1 of the path study. Addict Behav. 2019;91:180–7.
Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerström test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86(9):1119–27.
U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Food and Drug Administration, Center for Tobacco Products: Population Assessment of Tobacco and Health (PATH) Study [United States] Public Use-files: User Guide. Bethesda, Maryland: Inter-university Consortium for Political and Social Research; 2018.
Kasza KA, Edwards KC, Tang Z, Stanton CA, Sharma E, Halenar MJ, Taylor KA, Donaldson E, Hull LC, Day H, et al. Correlates of tobacco product initiation among youth and adults in the USA: findings from the PATH Study Waves 1–3 (2013–2016). Tob Control. 2020;29(Suppl 3):s191–202.
Pan W. Akaike’s information criterion in generalized estimating equations. Biometrics. 2001;57(1):120–5.
McNeill A, Brose L, Calder R, Simonavicius E, Robson D. Vaping in England: An evidence update including vaping for smoking cessation, February 2021. London: Public Health England; 2021. p. 1–247.
Sutton S. Social-psychological approaches to understanding addictive behaviours: attitude-behaviour and decision-making models. Br J Addict. 1987;82(4):355–70.
Biener L, Hargraves JL. A longitudinal study of electronic cigarette use among a population-based sample of adult smokers: association with smoking cessation and motivation to quit. Nicotine Tob Res. 2015;17(2):127–33.
Iles IA, Gillman AS, Klein WMP, Ferrer RA, Kaufman A: Associations between absolute and relative electronic cigarette harm perceptions and information-seeking behaviours among US adult current, former and never smokers. Drug Alcohol Rev. 2021;41(2):356–64.
Brose LS, Brown J, Hitchman SC, McNeill A. Perceived relative harm of electronic cigarettes over time and impact on subsequent use. A survey with 1-year and 2-year follow-ups. Drug Alcohol Depend. 2015;157:106–11.
Elton-Marshall T, Driezen P, Fong GT, Cummings KM, Persoskie A, Wackowski O, Choi K, Kaufman A, Strong D, Gravely S, et al. Adult perceptions of the relative harm of tobacco products and subsequent tobacco product use: Longitudinal findings from waves 1 and 2 of the population assessment of tobacco and health (PATH) study. Addict Behav. 2020;106:106337.
Wackowski OA, Delnevo CD. Young adults’ risk perceptions of various tobacco products relative to cigarettes: results from the national young adult health survey. Health Educ Behav. 2016;43(3):328–36.
Farsalinos KE, Romagna G, Voudris V. Factors associated with dual use of tobacco and electronic cigarettes: A case control study. Int J Drug Policy. 2015;26(6):595–600.
Wilson S, Partos T, McNeill A, Brose LS. Harm perceptions of e-cigarettes and other nicotine products in a UK sample. Addiction. 2019;114(5):879–88.
Dave D, Dench D, Kenkel D, Mathios A, Wang H. News that takes your breath away: risk perceptions during an outbreak of vaping-related lung injuries. J Risk Uncertain. 2020;60(3):281–307.
Wackowski OA, Gratale SK, Jeong M, Delnevo CD, Steinberg MB, O'Connor RJ. Over 1 year later: smokers’ EVALI awareness, knowledge and perceived impact on e-cigarette interest. Tobacco Control. 2022:tobaccocontrol-2021–057190.
Cohen G, Goldenson NI, Bailey PC, Chan S, Shiffman S. Changes in biomarkers of cigarette smoke exposure after 6 days of switching exclusively or partially to use of the JUUL system with two nicotine concentrations: a randomized controlled confinement study in adult smokers. Nicotine Tob Res 2021;23(12):2153–61.
Pulvers K, Nollen NL, Rice M, Schmid CH, Qu K, Benowitz NL, Ahluwalia JS. Effect of pod e-cigarettes vs cigarettes on carcinogen exposure among African American and latinx smokers: a randomized clinical trial. JAMA Netw Open. 2020;3(11):e2026324.
Yang B, Owusu D, Popova L. Testing messages about comparative risk of electronic cigarettes and combusted cigarettes. Tob Control. 2019;28(4):440–8.
Pepper JK, Byron MJ, Ribisl KM, Brewer NT. How hearing about harmful chemicals affects smokers’ interest in dual use of cigarettes and e-cigarettes. Prev Med. 2017;96:144–8.
Erku DA, Bauld L, Dawkins L, Gartner CE, Steadman KJ, Noar SM, Shrestha S, Morphett K. Does the content and source credibility of health and risk messages related to nicotine vaping products have an impact on harm perception and behavioural intentions? A systematic review. Addiction. 2021;116(12):3290–303.
Owusu D, Weaver SR, Yang B, Ashley DL, Popova L. Trends in trust in the sources of health information on E-cigarettes among US adults, 2015–2017. Am J Public Health. 2019;109(1):145–7.
Britton J, Bogdanovica I, McNeill A, Bauld L. Commentary on WHO Report on electronic nicotine delivery systems and electronic non-nicotine delivery systems. UK Centre for Tobacco & Alcohol Studies. 2016.
Liber A, Cahn Z, Larsen A, Drope J. Flavored E-cigarette sales in the United States under self-regulation from January 2015 through October 2019. Am J Public Health. 2020;110(6):785–7.
Ali FRM, Diaz MC, Vallone D, Tynan MA, Cordova J, Seaman EL, Trivers KF, Schillo BA, Talley B, King BA. E-cigarette unit sales, by product and flavor type - United States, 2014–2020. MMWR Morb Mortal Wkly Rep. 2020;69(37):1313–8.
Euromonitor International. Smokeless Tobacco, E-Vapour Products and Heated Tobacco in the US. London, UK; 2022.
Centers for Disease Control and Prevention: E-Cigarette, or vaping, products visual dictionary. Atlanta, GA. 2020.
Hajek P, Pittaccio K, Pesola F, Myers Smith K, Phillips-Waller A, Przulj D. Nicotine delivery and users’ reactions to Juul compared with cigarettes and other e-cigarette products. Addiction. 2020;115(6):1141–8.
Hajek P, Przulj D, Phillips A, Anderson R, McRobbie H. Nicotine delivery to users from cigarettes and from different types of e-cigarettes. Psychopharmacology. 2017;234(5):773–9.
Caponnetto P, DiPiazza J, Kim J, Maglia M, Polosa R. A single-arm, open-label, pilot, and feasibility study of a high nicotine strength E-cigarette intervention for smoking cessation or reduction for people with schizophrenia spectrum disorders who smoke cigarettes. Nicotine Tob Res. 2021;23(7):1113–22.